Research Labs

  • Focusing on genetic and molecular basis of antimalarial drug resistance in P. falciparum, antimalarial drug discovery, genetically attenuated parasite vaccines, parasite lipid metabolism.

    Members of the Fidock Lab
  • Dr. Sobieszczyk’s major investigative interest is the treatment and prevention of HIV and SARS-CoV-2.

    Members of the Hammer Lab
  • The Uhlemann Lab studies the evolution of drug resistance in bacteria and the relationship between intestinal microbiome and colonization with multi-drug resistant organisms.

    Members of the Uhlemann Lab
  • Dr. Yin’s research focuses on antiretroviral treatments for HIV and investigating non-infectious complications of HIV infeciton.